September 26, 2025BMC CancerOpen Access

CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy

View Full Paper

Ask AI

Bookmark

CDC6 is identified as a crucial oncogene with significantly elevated expression in melanoma and other cancers.
The analysis demonstrated strong correlations between cdc6 expression and immune cell infiltration patterns in various cancer types.
Systematic bioinformatics approaches integrated multi-omics datasets to evaluate cdc6's prognostic and immunological roles.
The findings propose CDC6 as a predictive biomarker for immunotherapy response, highlighting its potential therapeutic importance.

Discussion

No takes yet. Share an insight, caveat, or question.

Pan-cancer analysis reveals cdc6's role in tumor progression and immune microenvironment alterations.

Mo et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark